Breakthrough as new drug promises to shield child cancer patients from hearing loss
- OPACC
- Sep 13, 2023
- 1 min read
A new study, which is to be presented to the RNID Hearing Therapeutics Summit, found that a drug called Pedmark, also known as Pedmarqsi, lowers the risk of hearing loss brought on by cisplatin chemotherapy.
Comments